Category: Pharma Industry

News Alert

340B Providers, Drug Industry Raise Concerns Over HRSA’s 340B Rebate Model Pilot Proposal

July 31, 2025 Shannon Young, Associate Editor/Senior Writer Views

340B provider groups and drugmakers raised concerns Thursday over HRSA's proposed 340B rebate guidance.

340B covered entities and drugmakers offered competing criticisms Thursday of the Health Resources and Services Administration’s (HRSA) newly released 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Proposes 340B Rebate Model Pilot for Narrow Set of Drugs Under Strict Conditions

July 31, 2025 William Newton, Associate Editor/Senior Writer Views

The Health Resources and Services Administration published its highly-anticipated proposed 340B rebate guidance this morning, proposing a narrowly-scoped pilot program.

The Health Resources and Services Administration unveiled its highly anticipated proposed 340B rebate guidance on the morning of July 31.

The Health Resources and Services Administration (HRSA) today unveiled its highly anticipated 340B rebate guidance, proposing a pilot program that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Who Are the Federal Judges Deciding the High-Stakes Drugmaker 340B Rebate Appeals?

July 31, 2025 William Newton, Associate Editor/Senior Writer Views

Circuit Judges Neomi Rao, Patricia Millett and Cornelia Pillard are scheduled to hear oral arguments in Washington, D.C. this September on a five drug companies' 340B rebate appeal.

Three federal appeals judges—who have all ruled on 340B matters in the past—will hear oral arguments in September in a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Health Survey: Most Hospitals Would Struggle to Stay Open, Maintain Care Levels Under 340B Rebate Model

July 31, 2025 Shannon Young, Associate Editor/Senior Writer Views

340B Health surveyed hundreds of its member hospitals on the likely effects of drugmakers' proposed 340B rebate models.

A majority of 340B hospitals surveyed said the costs associated with implementing drugmakers’ proposed rebate models would hinder their ability [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Patient Groups Back Drugmakers in 340B Rebate Appeal, Without Disclosing Drug Industry Funding or Missed Compliance Deadline

July 29, 2025 William Newton, Associate Editor/Senior Writer Views

Three patient groups recently told a federal appeals court that a 340B rebate model “is essential to the effort to bring transparency to 340B.” One of those groups did not disclose its financial ties to drugmakers, and another is out of compliance with state public reporting laws.

Three patient groups are urging a federal appeals court to back drugmaker 340B rebate models they argue would bring transparency [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Alkermes, Novartis Exempt Additional States from 340B Contract Pharmacy Restrictions

July 29, 2025 Shannon Young, Associate Editor/Senior Writer Views

Alkermes is one of two drugmakers to recently announce new state exemptions to their 340B contract pharmacy restrictions.

Two major drugmakers recently announced new states that will be exempt from their 340B contract pharmacy restrictions following their enactment [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck, Eisai, Vertex to Refund 340B Covered Entities for Overcharges

July 29, 2025 Shannon Young, Associate Editor/Senior Writer Views

Merck, Eisai and Vertex will refund 340B covered entities that purchased certain medications between 2022 and 2025, according to notices posted on HRSA's website.

Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2025 following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Roundup: Updates in Colorado, Nebraska

July 24, 2025 William Newton, Associate Editor/Senior Writer Views

Key briefs were filed in Colorado and Nebraska in ongoing state 340B contract pharmacy litigation.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Matsui, Welch Reintroduce 340B PATIENTS Act in Congress During 340B Coalition Summer Conference

July 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

U.S. Rep. Doris Matsui (D-Calif.) and U.S. Sen. Peter Welch (D-Vt.) reintroduced the 340B PATIENTS Act during the 340B Coalition annual summer conference.

The two congressional Democrats behind the 340B PATIENTS Act—a 2024 federal bill that would’ve codified providers’ ability to use 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

OPA Director Touches on 340B Rebate Litigation and Other Key Matters at 340B Coalition Conference

July 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

Office of Pharmacy Affairs (OPA) Director Chantelle Britton addresses 340B stakeholders during remarks to open the 340B Coalition’s annual summer conference in National Harbor, Md. on Monday.

A key federal regulator highlighted the Health Resources and Services Administration’s (HRSA) legal fight against proposed drugmaker 340B rebate models [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live